Results from a prospective, open, non-comparative, multi-center clinical trial looking at the functionality and device performance of a new NPWT system* in the treatment of 38 acute, sub-acute or chronic wounds had a sub-set of 6 patients with exposed bone at baseline. Initial observations of rapid granulation tissue formation over bone was supported by further analysis of this sub-set of patients demonstrating a change in the median percentage of beefy red (healthy granulation) tissue from 70% at baseline assessment to 92.5% at treatment discontinuation. The rapid formation of granulation tissue and blood vessels are essential to healing these wounds and the results from this sub-set of patients further supports the consensus of using NPWT as an adjunctive therapy in patients with exposed bone and tendon to descend the reconstructive ladder.